Cardlytics (CDLX) Tops Q2 EPS by 31c

Cardlytics (NASDAQ: CDLX) reported Q2 EPS of ($0.15), $0.31 better than the analyst estimate of ($0.46). Revenue for the quarter came in at $69.64 million versus the consensus estimate of $75.39 million.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.

You May Also Be Interested In

• KeyBanc Starts PPG Industries (PPG) at Overweight
• Copart (CPRT) Misses Q4 EPS by 4c
• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance